| Entry |
|
|---|
| Name |
Triphosadenine (DCF);
ATP |
|---|
| Formula |
C10H16N5O13P3
|
|---|
| Exact mass |
506.9957
|
|---|
| Mol weight |
507.18
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG00243): | D00045<JP/US> D02300<JP> |
|
|---|
| Efficacy |
Vasodilator |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01E OTHER CARDIAC PREPARATIONS
C01EB Other cardiac preparations
C01EB10 Adenosine
D08646 Triphosadenine (DCF)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Adenosinetriphosphoric acid
D08646 Triphosadenine (DCF)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA
D08646 Triphosadenine (DCF)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 31
1 N4y N 28.9800 -17.1500
2 C8y C 30.0300 -17.8500
3 C1y C 27.7200 -17.5700
4 C8x C 29.4700 -15.7500
5 C8y C 31.2900 -16.9400
6 N5x N 30.1700 -19.2500
7 O2x O 26.6000 -16.6600
8 C1y C 27.3000 -18.7600
9 N5x N 30.9400 -15.7500
10 C8y C 32.5500 -17.5000
11 C8x C 31.5000 -19.8800
12 C1y C 25.4800 -17.5000
13 C1y C 25.9000 -18.7600
14 O1a O 28.0700 -19.9500
15 N5x N 32.6900 -18.9700
16 N1a N 33.6700 -16.6600
17 C1b C 24.1500 -17.0800
18 O1a O 25.4800 -20.0900
19 O2b O 23.1000 -17.9900
20 P1b P 21.7000 -17.9900
21 O2c O 20.3000 -17.9900
22 O1c O 21.7000 -19.3900
23 O1c O 21.7000 -16.5900
24 P1b P 18.9000 -17.9900
25 O2c O 17.5000 -17.9900
26 O1c O 18.9000 -19.3900
27 O1c O 18.9000 -16.5900
28 P1b P 16.1000 -17.9900
29 O1c O 16.1000 -19.3900
30 O1c O 14.7000 -17.9900
31 O1c O 16.1000 -16.5900
BOND 33
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 8 14 1 #Down
14 10 15 2
15 10 16 1
16 12 17 1 #Up
17 13 18 1 #Down
18 17 19 1
19 19 20 1
20 20 21 1
21 20 22 1
22 20 23 2
23 21 24 1
24 24 25 1
25 24 26 1
26 24 27 2
27 25 28 1
28 28 29 1
29 28 30 1
30 28 31 2
31 5 9 1
32 11 15 1
33 12 13 1
|
|---|
